These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 7931623

  • 1. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T, Nomura T, Bartus RT, Black KL.
    J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
    [Abstract] [Full Text] [Related]

  • 2. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL.
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [Abstract] [Full Text] [Related]

  • 3. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
    Inamura T, Black KL.
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
    [Abstract] [Full Text] [Related]

  • 4. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7.
    Nakano S, Matsukado K, Black KL.
    Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027
    [Abstract] [Full Text] [Related]

  • 5. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
    Liu Y, Hashizume K, Samoto K, Sugita M, Ningaraj N, Asotra K, Black KL.
    Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
    Sugita M, Hunt GE, Liu Y, Black KL.
    Neurol Res; 1998 Sep; 20(6):559-63. PubMed ID: 9713849
    [Abstract] [Full Text] [Related]

  • 12. Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma.
    Inamura T, Nomura T, Ikezaki K, Fukui M, Pöllinger G, Black KL.
    Neurol Res; 1994 Apr; 16(2):125-8. PubMed ID: 7913997
    [Abstract] [Full Text] [Related]

  • 13. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
    Black KL, Cloughesy T, Huang SC, Gobin YP, Zhou Y, Grous J, Nelson G, Farahani K, Hoh CK, Phelps M.
    J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
    [Abstract] [Full Text] [Related]

  • 14. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K, Nakano S, Bartus RT, Black KL.
    Acta Neurochir Suppl; 1997 Apr; 70():159-61. PubMed ID: 9416308
    [Abstract] [Full Text] [Related]

  • 15. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
    Bartus RT, Elliott PJ, Dean RL, Hayward NJ, Nagle TL, Huff MR, Snodgrass PA, Blunt DG.
    Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
    [Abstract] [Full Text] [Related]

  • 16. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
    Black KL, King WA, Ikezaki K.
    J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
    [Abstract] [Full Text] [Related]

  • 17. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
    Matsukado K, Sugita M, Black KL.
    Brain Res; 1998 May 04; 792(1):10-5. PubMed ID: 9593802
    [Abstract] [Full Text] [Related]

  • 18. Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.
    Chio CC, Lin SJ, Lin MT.
    J Neurooncol; 1995 May 04; 25(2):89-95. PubMed ID: 8543974
    [Abstract] [Full Text] [Related]

  • 19. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC, Baba T, Black KL.
    J Neurosurg; 1992 Sep 04; 77(3):407-10. PubMed ID: 1506887
    [Abstract] [Full Text] [Related]

  • 20. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan 04; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.